BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1723959)

  • 21. [Carcinoma of Bellini's tubules].
    Rousseau T; Lesourd A; Meria P; Desgrandchamps F; Cussenot O; Cortesse A; Teillac P; Le Duc A
    Prog Urol; 1995 Jun; 5(3):402-5; discussion 405-6. PubMed ID: 7545498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphous low-grade adenocarcinoma of the parotid gland.
    O'Rourke AK; Gourin CG; Wade ZK; Hessler RB
    Ear Nose Throat J; 2006 Oct; 85(10):669-71. PubMed ID: 17124941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caecal adenocarcinoma with rhabdoid phenotype: an immunohistochemical and ultrastructural analysis.
    Chetty R; Bhathal PS
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(2):179-82. PubMed ID: 7682022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphous low-grade adenocarcinoma of left parotid gland.
    Gelincik I; Bayram I; Cankaya H
    Indian J Pathol Microbiol; 2010; 53(1):166-7. PubMed ID: 20090256
    [No Abstract]   [Full Text] [Related]  

  • 25. Polymorphous low-grade adenocarcinoma of minor salivary gland. A comparative histologic and immunohistochemical study.
    Regezi JA; Zarbo RJ; Stewart JC; Courtney RM
    Oral Surg Oral Med Oral Pathol; 1991 Apr; 71(4):469-75. PubMed ID: 1711187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An immunohistochemical study of epithelial membrane antigen, cytokeratin, and vimentin in papillary thyroid carcinoma. Recognition of lethal and favorable prognostic types.
    Yamamoto Y; Izumi K; Otsuka H
    Cancer; 1992 Nov; 70(9):2326-33. PubMed ID: 1382831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphous low-grade adenocarcinoma of the parotid gland.
    Barak AP; Grobbel MA; Rabaja DR
    Am J Otolaryngol; 1998; 19(5):322-4. PubMed ID: 9758181
    [No Abstract]   [Full Text] [Related]  

  • 28. Pancreatic mucinous cystadenocarcinoma with pseudosarcomatous mural nodules. A report of a case with immunohistochemical study.
    García Rego JA; Valbuena Ruvira L; Alvarez García A; Santiago Freijanes MP; Suárez Peñaranda JM; Rois Soto JM
    Cancer; 1991 Jan; 67(2):494-8. PubMed ID: 1702351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demonstration of cytokeratins and an epithelial membrane antigen in chondroid chordoma.
    Salisbury JR
    J Pathol; 1987 Sep; 153(1):37-40. PubMed ID: 2444686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salivary duct carcinoma: cytokeratin 14 as a marker of in-situ intraductal growth.
    de Araújo VC; Kowalski LP; Soares F; de Araújo NS; Loducca SV; Sobral AP
    Histopathology; 2002 Sep; 41(3):244-9. PubMed ID: 12207786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clear cell eccrine carcinomas of the skin. A clinicopathologic study of nine patients.
    Wong TY; Suster S; Nogita T; Duncan LM; Dickersin RG; Mihm MC
    Cancer; 1994 Mar; 73(6):1631-43. PubMed ID: 7512435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphoepithelioma-like carcinoma vs inflamed squamous cell carcinoma of the skin.
    Wang G; Bordeaux JS; Rowe DJ; Honda KS
    JAMA Dermatol; 2014 Dec; 150(12):1367-8. PubMed ID: 25102913
    [No Abstract]   [Full Text] [Related]  

  • 33. Clear cell tumors of minor salivary gland origin. An immunohistochemical and ultrastructural analysis.
    Ogawa I; Nikai H; Takata T; Ijuhin N; Miyauchi M; Ito H; Vuhahula E
    Oral Surg Oral Med Oral Pathol; 1991 Aug; 72(2):200-7. PubMed ID: 1717916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Parotid gland carcinosarcoma: report of a case].
    Zhang HP; Zhang HF; Chen PQ
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):703-4. PubMed ID: 22321553
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunohistochemical analysis of salivary gland canalicular adenoma.
    Ferreiro JA
    Oral Surg Oral Med Oral Pathol; 1994 Dec; 78(6):761-5. PubMed ID: 7534898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary synovial sarcoma of the parotid gland: An unusual entity.
    Sharma A; Tyagi M; Gupta S; Arora VK
    Indian J Pathol Microbiol; 2016; 59(4):559-560. PubMed ID: 27721300
    [No Abstract]   [Full Text] [Related]  

  • 37. Polymorphous low-grade adenocarcinoma of the parotid gland. Case report and review of the literature.
    Ruíz-Godoy L; Suárez L; Mosqueda A; Meneses A
    Med Oral Patol Oral Cir Bucal; 2007 Jan; 12(1):E30-3. PubMed ID: 17195824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemistry of capillary hemangioblastoma. Immunoperoxidase-labeled antibody staining resolves the differential diagnosis with metastatic renal cell carcinoma, but does not explain the histogenesis of the capillary hemangioblastoma.
    Hufnagel TJ; Kim JH; True LD; Manuelidis EE
    Am J Surg Pathol; 1989 Mar; 13(3):207-16. PubMed ID: 2465700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of cluster of differentiation 9 glycoprotein in benign and malignant parotid gland tumours.
    Sakamoto K; Ono T; Nakamura Y; Harada H; Nakashima T
    J Laryngol Otol Suppl; 2009; (31):58-63. PubMed ID: 19460206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Myoepithelial-epithelial carcinoma of the parotid: cyto-histological description of a case].
    Zocchi M; Nicosia G; Ramponi A; Pisani P; Boldorini R
    Pathologica; 1995 Oct; 87(5):534-38. PubMed ID: 8868183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.